AG真人官方

STOCK TITAN

[144] Aura Biosciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

AURA Form 144 notice reports a proposed sale of 7,722 common shares acquired by stock option exercise on 08/18/2025. The sale is to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ with an aggregate market value of $51,750.53 based on the filing. The filing states there were 62,119,873 shares outstanding at the time. No other securities were reported sold in the prior three months and payment for the acquired shares was in cash.

Avviso AURA Modulo 144 comunica una proposta di vendita di 7,722 azioni ordinarie acquisite tramite esercizio di opzioni su azioni in data 08/18/2025. La vendita sar脿 eseguita tramite Morgan Stanley Smith Barney LLC sul NASDAQ per un valore di mercato complessivo di $51,750.53 secondo la dichiarazione. Il documento riporta che al momento risultavano in circolazione 62,119,873 azioni. Nei tre mesi precedenti non sono stati segnalati altri titoli venduti e il pagamento per le azioni acquisite 猫 stato effettuato in contanti.

Notificaci贸n AURA Form 144 informa sobre una propuesta de venta de 7,722 acciones ordinarias adquiridas mediante ejercicio de opciones sobre acciones el 08/18/2025. La venta se ejecutar谩 a trav茅s de Morgan Stanley Smith Barney LLC en el NASDAQ, con un valor de mercado agregado de $51,750.53 seg煤n la presentaci贸n. La documentaci贸n indica que en ese momento hab铆a 62,119,873 acciones en circulaci贸n. No se informaron otras ventas de valores en los tres meses anteriores y el pago de las acciones adquiridas fue en efectivo.

AURA 鞏戩嫕 144 瓿奠电� 08/18/2025鞐� 鞀ろ啞 鞓奠厴 頄夓偓搿� 旆摑頃� 7,722 氤错喌欤茧ゼ 毵る弰頃橂牑电� 鞝滌晥鞚� 氤搓碃頃╇媹雼�. 頃措嫻 毵る弰电� Morgan Stanley Smith Barney LLC毳� 韱淀暣 NASDAQ鞐愳劀 鞁ろ枆霅� 鞓堨爼鞚措┌, 鞝滌稖靹滌棎 霐半ゴ氅� 齑� 鞁滌灔 臧旃樀鐢 $51,750.53鞛呺媹雼�. 鞝滌稖靹滌棎电� 雼轨嫓 氚滍枆 欤检嫕靾橁皜 62,119,873欤检榾雼り碃 旮办灛霅橃柎 鞛堨姷雼堧嫟. 歆侅爠 3臧滌洈 霃欖晥 雼るジ 鞙犼皜歃濌秾鞚� 毵る弰电� 氤搓碃霅橃 鞎婌晿瓿�, 旆摑頃� 欤检嫕 雽旮堨潃 顺勱笀鞙茧 歆旮夒悩鞐堨姷雼堧嫟.

Avis AURA Formulaire 144 signale une proposition de vente de 7,722 actions ordinaires acquises par exercice d'options sur actions le 08/18/2025. La vente sera effectu茅e via Morgan Stanley Smith Barney LLC sur le NASDAQ, pour une valeur marchande totale de $51,750.53 selon le d茅p么t. Le document indique qu'il y avait 62,119,873 actions en circulation 脿 ce moment-l脿. Aucun autre titre n'a 茅t茅 d茅clar茅 vendu au cours des trois mois pr茅c茅dents et le paiement des actions acquises a 茅t茅 effectu茅 en 别蝉辫猫肠别蝉.

AURA Form 144-Mitteilung meldet einen geplanten Verkauf von 7,722 Stammaktien, die durch Aus眉bung von Aktienoptionen am 08/18/2025 erworben wurden. Der Verkauf soll 眉ber Morgan Stanley Smith Barney LLC an der NASDAQ ausgef眉hrt werden und hat laut Einreichung einen Gesamtmarktwert von $51,750.53. In der Einreichung wird angegeben, dass zu diesem Zeitpunkt 62,119,873 Aktien im Umlauf waren. In den vorangegangenen drei Monaten wurden keine weiteren Wertpapiere als verkauft gemeldet und die Bezahlung der erworbenen Aktien erfolgte in Bargeld.

Positive
  • Full Rule 144 disclosure provided including acquisition method, broker, and aggregate market value
  • Sale size is small relative to outstanding shares (7,722 vs 62,119,873), indicating limited market impact
Negative
  • Insider is selling shares, which some investors may interpret negatively despite immaterial size
  • No context on insider role or holding post-sale is provided in the filing

Insights

TL;DR Routine insider sale from option exercise totaling 7,722 shares, small relative to outstanding shares.

The filing documents a controlled sale of shares acquired via stock option exercise on 08/18/2025. At an aggregate value of $51,750.53, the transaction is immaterial versus the reported 62,119,873 shares outstanding, indicating limited direct impact on share supply or company capitalization. This disclosure is standard and satisfies Rule 144 notice requirements.

TL;DR Compliance-oriented filing showing insider sale; provides transparency but no material governance signal.

The Form 144 confirms the seller represents they possess no undisclosed material adverse information and that the sale will be routed through Morgan Stanley Smith Barney LLC. The notice includes the acquisition method (option exercise) and payment in cash, aligning with standard disclosure practices. Absence of additional sales in the prior three months reduces concerns about pattern selling.

Avviso AURA Modulo 144 comunica una proposta di vendita di 7,722 azioni ordinarie acquisite tramite esercizio di opzioni su azioni in data 08/18/2025. La vendita sar脿 eseguita tramite Morgan Stanley Smith Barney LLC sul NASDAQ per un valore di mercato complessivo di $51,750.53 secondo la dichiarazione. Il documento riporta che al momento risultavano in circolazione 62,119,873 azioni. Nei tre mesi precedenti non sono stati segnalati altri titoli venduti e il pagamento per le azioni acquisite 猫 stato effettuato in contanti.

Notificaci贸n AURA Form 144 informa sobre una propuesta de venta de 7,722 acciones ordinarias adquiridas mediante ejercicio de opciones sobre acciones el 08/18/2025. La venta se ejecutar谩 a trav茅s de Morgan Stanley Smith Barney LLC en el NASDAQ, con un valor de mercado agregado de $51,750.53 seg煤n la presentaci贸n. La documentaci贸n indica que en ese momento hab铆a 62,119,873 acciones en circulaci贸n. No se informaron otras ventas de valores en los tres meses anteriores y el pago de las acciones adquiridas fue en efectivo.

AURA 鞏戩嫕 144 瓿奠电� 08/18/2025鞐� 鞀ろ啞 鞓奠厴 頄夓偓搿� 旆摑頃� 7,722 氤错喌欤茧ゼ 毵る弰頃橂牑电� 鞝滌晥鞚� 氤搓碃頃╇媹雼�. 頃措嫻 毵る弰电� Morgan Stanley Smith Barney LLC毳� 韱淀暣 NASDAQ鞐愳劀 鞁ろ枆霅� 鞓堨爼鞚措┌, 鞝滌稖靹滌棎 霐半ゴ氅� 齑� 鞁滌灔 臧旃樀鐢 $51,750.53鞛呺媹雼�. 鞝滌稖靹滌棎电� 雼轨嫓 氚滍枆 欤检嫕靾橁皜 62,119,873欤检榾雼り碃 旮办灛霅橃柎 鞛堨姷雼堧嫟. 歆侅爠 3臧滌洈 霃欖晥 雼るジ 鞙犼皜歃濌秾鞚� 毵る弰电� 氤搓碃霅橃 鞎婌晿瓿�, 旆摑頃� 欤检嫕 雽旮堨潃 顺勱笀鞙茧 歆旮夒悩鞐堨姷雼堧嫟.

Avis AURA Formulaire 144 signale une proposition de vente de 7,722 actions ordinaires acquises par exercice d'options sur actions le 08/18/2025. La vente sera effectu茅e via Morgan Stanley Smith Barney LLC sur le NASDAQ, pour une valeur marchande totale de $51,750.53 selon le d茅p么t. Le document indique qu'il y avait 62,119,873 actions en circulation 脿 ce moment-l脿. Aucun autre titre n'a 茅t茅 d茅clar茅 vendu au cours des trois mois pr茅c茅dents et le paiement des actions acquises a 茅t茅 effectu茅 en 别蝉辫猫肠别蝉.

AURA Form 144-Mitteilung meldet einen geplanten Verkauf von 7,722 Stammaktien, die durch Aus眉bung von Aktienoptionen am 08/18/2025 erworben wurden. Der Verkauf soll 眉ber Morgan Stanley Smith Barney LLC an der NASDAQ ausgef眉hrt werden und hat laut Einreichung einen Gesamtmarktwert von $51,750.53. In der Einreichung wird angegeben, dass zu diesem Zeitpunkt 62,119,873 Aktien im Umlauf waren. In den vorangegangenen drei Monaten wurden keine weiteren Wertpapiere als verkauft gemeldet und die Bezahlung der erworbenen Aktien erfolgte in Bargeld.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Aura Biosciences (AURA) report in this Form 144?

The Form 144 reports a proposed sale of 7,722 common shares acquired by stock option exercise on 08/18/2025 with an aggregate market value of $51,750.53.

Through which broker will the AURA shares be sold?

The filing states the broker as Morgan Stanley Smith Barney LLC located at 1 New York Plaza, New York, NY.

How many Aura shares were outstanding according to the filing?

The filing lists 62,119,873 shares outstanding.

Was payment for the acquired securities made in cash?

Yes. The filing indicates the shares were acquired by option exercise and payment was made in cash on 08/18/2025.

Did the filer report other sales in the past three months?

The filing states Nothing to Report for securities sold during the past three months.
Aura Biosciences, Inc.

NASDAQ:AURA

AURA Rankings

AURA Latest News

AURA Latest SEC Filings

AURA Stock Data

398.81M
55.74M
1.98%
84.55%
4.46%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
BOSTON